VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer

Although probiotics have shown success in preventing the development of experimental colitis-associated colorectal cancer (CRC), beneficial effects of interventional treatment are relatively unknown. Here we show that interventional treatment with VSL#3 probiotic alters the luminal and mucosally-adh...

Descripción completa

Detalles Bibliográficos
Autores principales: Arthur, Janelle C., Gharaibeh, Raad Z., Uronis, Joshua M., Perez-Chanona, Ernesto, Sha, Wei, Tomkovich, Sarah, Mühlbauer, Marcus, Fodor, Anthony A., Jobin, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792409/
https://www.ncbi.nlm.nih.gov/pubmed/24100376
http://dx.doi.org/10.1038/srep02868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792409/
https://www.ncbi.nlm.nih.gov/pubmed/24100376
http://dx.doi.org/10.1038/srep02868

Ejemplares similares